Posibles problemas de falta de objetividad, transparencia, doble publicación y autoría en el análisis coste-efectividad de celecoxib

Peiró, S.; Meneu, R.; Ortún, V.; Puig, J.

doi:10.1016/S0213-9111(03)71763-4

array:24 ["pii" => "S0213911103717634" "issn" => "02139111" "doi" => "10.1016/S0213-9111(03)71763-4" "estado" => "S300" "fechaPublicacion" => "2003-07-01" "aid" => "71763" "copyright" => "Sociedad Española de Salud Pública y Administración Sanitaria" "copyrightAnyo" => "2003" "documento" => "article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "cor" "cita" => "Gac Sanit. 2003;17:342-4" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2695 "formatos" => array:3 [ "EPUB" => 93 "HTML" => 2237 "PDF" => 365 ] ] "itemSiguiente" => array:19 [ "pii" => "S0213911103717646" "issn" => "02139111" "doi" => "10.1016/S0213-9111(03)71764-6" "estado" => "S300" "fechaPublicacion" => "2003-07-01" "aid" => "71764" "copyright" => "Sociedad Española de Salud Pública y Administración Sanitaria" "documento" => "article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "cor" "cita" => "Gac Sanit. 2003;17:345-6" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1865 "formatos" => array:3 [ "EPUB" => 87 "HTML" => 1355 "PDF" => 423 ] ] "es" => array:8 [ "idiomaDefecto" => true "titulo" => "Réplica" "tienePdf" => "es" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "345" "paginaFinal" => "346" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Author's reply" ] ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "A. Moreno, E. Vargas, J. Soto, J. Rejas" "autores" => array:4 [ 0 => array:2 [ "nombre" => "A." "apellidos" => "Moreno" ] 1 => array:2 [ "nombre" => "E." "apellidos" => "Vargas" ] 2 => array:2 [ "nombre" => "J." "apellidos" => "Soto" ] 3 => array:2 [ "nombre" => "J." "apellidos" => "Rejas" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213911103717646?idApp=WGSE" "url" => "/02139111/0000001700000004/v1_201310251607/S0213911103717646/v1_201310251607/es/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S0213911103717622" "issn" => "02139111" "doi" => "10.1016/S0213-9111(03)71762-2" "estado" => "S300" "fechaPublicacion" => "2003-07-01" "aid" => "71762" "copyright" => "Sociedad Española de Salud Pública y Administración Sanitaria" "documento" => "article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "cor" "cita" => "Gac Sanit. 2003;17:341" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2389 "formatos" => array:3 [ "EPUB" => 98 "HTML" => 1901 "PDF" => 390 ] ] "es" => array:8 [ "idiomaDefecto" => true "titulo" => "Denuncias por agresión a mujeres en la Plana Baixa (Castellón)" "tienePdf" => "es" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "341" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Formal complaints of assault against women in Plana Baixa in Castellón, Spain" ] ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "V.A. Arrufat Gallén, J. Criado Juárez, C. Colomer Revuelta, S. Albert Linares, R. Sánchez Diago" "autores" => array:5 [ 0 => array:2 [ "nombre" => "V.A." "apellidos" => "Arrufat Gallén" ] 1 => array:2 [ "nombre" => "J." "apellidos" => "Criado Juárez" ] 2 => array:2 [ "nombre" => "C." "apellidos" => "Colomer Revuelta" ] 3 => array:2 [ "nombre" => "S." "apellidos" => "Albert Linares" ] 4 => array:2 [ "nombre" => "R." "apellidos" => "Sánchez Diago" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213911103717622?idApp=WGSE" "url" => "/02139111/0000001700000004/v1_201310251607/S0213911103717622/v1_201310251607/es/main.assets" ] "es" => array:9 [ "idiomaDefecto" => true "titulo" => "Posibles problemas de falta de objetividad, transparencia, doble publicación y autoría en el análisis coste-efectividad de celecoxib" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "342" "paginaFinal" => "344" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "S. Peiró, R. Meneu, V. Ortún, J. Puig" "autores" => array:4 [ 0 => array:3 [ "nombre" => "S." "apellidos" => "Peiró" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] ] ] 1 => array:3 [ "nombre" => "R." "apellidos" => "Meneu" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] ] ] 2 => array:3 [ "nombre" => "V." "apellidos" => "Ortún" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "b" "identificador" => "aff0010" ] ] ] 3 => array:3 [ "nombre" => "J." "apellidos" => "Puig" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "b" "identificador" => "aff0010" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Fundació Institut de Investigació en Serveis de Salut. València" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Centre de Recerca en Economia i Salut (CRES). Universitat Pompeu Fabra. Barcelona. España" "etiqueta" => "b" "identificador" => "aff0010" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Possible problems of lack of objectivity, transparency, duplicate publication and authorship in the cost-effectiveness analysis of celecoxib" ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "bibliografia" => array:2 [ "titulo" => "Bibliografía" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:17 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Análisis coste-efectividad del empleo de celecoxib en el tratamiento de la artrosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "A. Moreno" 1 => "E. Vargas" 2 => "J. Soto" 3 => "J. Rejas" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Gac Sanit" "fecha" => "2003" "volumen" => "17" "paginaInicial" => "27" "paginaFinal" => "36" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12605743" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Gastrointestinal toxicity with celecoxib vs non-steroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS study: a randomised controlled trial. Celecoxib Long-term Arthritis Safety Study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "F.E. Silverstein" 1 => "G. Faich" 2 => "J.L. Goldstein" 3 => "L.S. Simon" 4 => "T. Pincus" 5 => "A. Whelton" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Am Med J" "fecha" => "2000" "volumen" => "284" "paginaInicial" => "1247" "paginaFinal" => "1255" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3." "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Witter J. Medical officer review. Consultado el 31 de marzo, 2003. Disponible en: <a class="elsevierStyleInterRef" href="http://www.fda.gov/ohrms/dockets/ac/01/briefing/3677b1_03_med.pdf">www.fda.gov/ohrms/dockets/ac/01/briefing/3677b1_03_med.pdf</a>" ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4." "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Lu HL. Statistical reviewer briefing document for the advisory committee. Consultado el 31 de marzo de 2003. Disponible en: <a class="elsevierStyleInterRef" href="http://www.fda.gov/ohrms/dockets/ac/01/briefing/3677b1_04_stats.doc">www.fda.gov/ohrms/dockets/ac/01/briefing/3677b1_04_stats.doc</a>" ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs? Adequate analysis of the CLASS trial indicates that this may not be the case" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "P. Jüni" 1 => "A.W.S. Rutjes" 2 => "P.A. Dieppe" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "BMJ" "fecha" => "2002" "volumen" => "324" "paginaInicial" => "1287" "paginaFinal" => "1288" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12039807" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "CLASS clarification: reaffirms the medical importance of the analyses and results. The authors respond" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "P. Jüni" 1 => "A.W.S. Rutjes" 2 => "P.A. Dieppe" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "BMJ" "fecha" => "2002" "volumen" => "325" "paginaInicial" => "523" "paginaFinal" => "524" ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Reporting of 6-month vs 12-month data in a clinical trial of celecoxib (in reply)" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "F. Silverstein" 1 => "L. Simon" 2 => "G. Faich" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "J Am Med Assoc" "fecha" => "2001" "volumen" => "286" ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Are selective COX 2 inhibitors superior to traditional NSAIDs? Pharmacia's response to editorial" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "G.S. Geis" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "BMJ" "fecha" => "2002" "volumen" => "325" "paginaInicial" => "161" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12134855" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "CLASS clarification: reaffirms the medical importance of the analyses and results" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "G.S. Geis" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "BMJ" "fecha" => "2002" "volumen" => "325" "paginaInicial" => "522" "paginaFinal" => "523" ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0050" "etiqueta" => "10." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "J.J. Deeks" 1 => "L.A. Smith" 2 => "M.D. Bradley" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "BMJ" "fecha" => "2002" "volumen" => "325" "paginaInicial" => "619" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12242171" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0055" "etiqueta" => "11." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Systematic review of celecoxib for osteoarthritis and rheumatoid arthritis. Problems compromise review's validity" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "P. Juni" 1 => "R. Sterchi" 2 => "P. Dieppe" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "BMJ" "fecha" => "2003" "volumen" => "326" "paginaInicial" => "334" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12575714" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0060" "etiqueta" => "12." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Risk of cardiovascular events associated with selective COX-2 inhibitors" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "D. Mukherjee" 1 => "S.E. Nissen" 2 => "E.J. Topol" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Am Med Assoc" "fecha" => "2001" "volumen" => "286" "paginaInicial" => "954" "paginaFinal" => "959" ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0065" "etiqueta" => "13." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C. Bombardier" 1 => "L. Laine" 2 => "A. Reicin" 3 => "D. Shapiro" 4 => "R. Burgos-Vargas" 5 => "B. Davis" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJM200011233432103" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2000" "volumen" => "343" "paginaInicial" => "1520" "paginaFinal" => "1528" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11087881" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0070" "etiqueta" => "14." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Digging for data from the COX-2 trials" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "J.P. McCormack" 1 => "R. Rangno" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Can Med J Assoc" "fecha" => "2002" "volumen" => "166" "paginaInicial" => "1649" "paginaFinal" => "1650" ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0075" "etiqueta" => "15." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "La declaración del conflicto de intereses en las publicaciones científicas. ¿Tiempo para las luces y los taquígrafos en la trastienda de la investigación financiada por la industria?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "S. Peiró" 1 => "S. Peiró" 2 => "A. García-Altes" 3 => "R. Meneu" 4 => "J. Librero" 5 => "E. Bernal" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Gac Sanit" "fecha" => "2000" "volumen" => "14" "paginaInicial" => "472" "paginaFinal" => "481" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11270174" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0080" "etiqueta" => "16." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Evaluación económica de celecoxib en el tratamiento de la artrosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "E. Vargas" 1 => "L. Laredo" 2 => "J. Soto" 3 => "J. Rejas" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Aten Farmacéutica" "fecha" => "2002" "volumen" => "4" "paginaInicial" => "72" "paginaFinal" => "82" ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0085" "etiqueta" => "17." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Análisis fármacoeconómico del uso de celecoxib en el tratamiento de la artrosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "J. Soto" 1 => "A. Belén Romero" 2 => "J. Rejas" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Rev Esp Reumatol" "fecha" => "2002" "volumen" => "29" "paginaInicial" => "142" "paginaFinal" => "150" ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "es" "url" => "/02139111/0000001700000004/v1_201310251607/S0213911103717634/v1_201310251607/es/main.assets" "Apartado" => array:4 [ "identificador" => "677" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Cartas al Director" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/02139111/0000001700000004/v1_201310251607/S0213911103717634/v1_201310251607/es/main.pdf?idApp=WGSE&text.app=https://gacetasanitaria.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213911103717634?idApp=WGSE"]

Gaceta Sanitaria

ISSN: 0213-9111

Gaceta Sanitaria es la revista científica y órgano de expresión de la Sociedad Española de Salud Pública y Administración Sanitaria (SESPAS).
Gaceta Sanitaria acepta para su publicación artículos en español e inglés. Es una revista Open Access (OA); todos sus artículos son accesibles libremente sin cargo para el usuario y se distribuyen con la licencia Creative Commons Reconocimiento-NoComercial-SinObraDerivada 4.0 Internacional

Call for papers: Special Issue on Health Economics

Convocatoria abierta y permanente para incorporar Editores/as asociados/as al Comité Editorial de Gaceta Sanitaria

Call for papers: Special Issue on Health Economics

Open and permanent call to incorporate Associate Editors to the Editorial Committee of Gaceta Sanitaria

Indexada en:

Web of Science (Science Citation Index, SCI, y Social Sciences Citation Index, SSCI), Medline/PubMed, Index Medicus, Scopus, Scielo, IBECS, Índice Médico Español, Toxline, Cancerlit, Aidsline, Cab Health, Bibliomed, Cuiden, Eventline y Healthstar

Indexada en:

Síguenos:

Suscríbase a la newsletter